France-based Sierra Leonean rapper Mos-B has released a single titled ‘Vaccinate’. The track is available for streaming and download across major digital platforms.
‘Vaccinate’ is a follow up to his 2020 record ‘War Against Corona’. It was written and produced by Mos-B with final productions by Panash of Shockwave Music in Zimbabwe and seeks to encourage people to get vaccinated against COVID-19.
“I encourage Africans and the rest of the world to vaccinate,” Mos-B told Music In Africa. “The inspiration came from a British friend behind the Spratley Charity Foundation and a call from a Sierra Leonean radio broadcaster who called me to suggest that I do a song encouraging Sierra Leoneans and Africans to vaccinate. The song style I chose this time is funk and there is a little touch of African sounds.”
Mos-B noted that he was unhappy with the rollout of vaccines in Africa. “I feel like Africans are not taking the vaccination too serious,” he said.
“In 2020 I released the coronavirus song because I knew Africans were in denial or did not believe it's real. After the release, BBC interviewed me and I received a lot of feedback from Africans thanking me for the brilliant message.”
Throughout his career, Mos-B has released successful singles such as ‘Traveller’, ‘Voices of the Wind’, ‘Bell of Freedom’ and ‘Back to My Roots and Culture’. He is also known for his 2018 album New Chapter.
Listen to ‘Vaccinate’ below:
Most popular
Top Naija songs of 2026
31 Mar 2026
Top amapiano songs of 2026
16 Feb 2026
Top Afrobeats songs of 2026
19 Mar 2026
AFRIMA 2026: All the winners
12 Jan 2026
Open call: CANEX Creative Pitch for African creative enterprises
29 Sep 2026
Goethe-Institut Kenya brings Ghanaian and Kenyan artists together for MobiArts concert
05 Oct 2026
Disclaimer: Music In Africa provides a platform for musicians and contributors to embed music and videos solely for promotional purposes. If any track or video embedded on this platform violates any copyrights please inform us immediately and we will take it down. Please read our Terms of Use for more.
Please log in to post a comment.